| Product Code: ETC6349155 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium saw a notable increase in the import of buccal drug delivery systems, with top exporting countries being Italy, Germany, USA, Metropolitan France, and Switzerland. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), shifted from low to moderate concentration, indicating a more balanced distribution among suppliers. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 6.48%, although there was a slight decline in growth rate from 2023 to 2024 at -0.52%. These trends suggest a growing market with diverse sources of imports for buccal drug delivery systems in Belgium.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Buccal Drug Delivery Systems Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Buccal Drug Delivery Systems Market - Industry Life Cycle |
3.4 Belgium Buccal Drug Delivery Systems Market - Porter's Five Forces |
3.5 Belgium Buccal Drug Delivery Systems Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Belgium Buccal Drug Delivery Systems Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium Buccal Drug Delivery Systems Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Belgium Buccal Drug Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Belgium, leading to a higher demand for more effective drug delivery systems. |
4.2.2 Growing geriatric population in Belgium, who prefer easy-to-administer drug delivery methods like buccal systems. |
4.2.3 Technological advancements in drug delivery systems, making buccal delivery more efficient and convenient. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Belgium may pose challenges for the introduction of new buccal drug delivery systems. |
4.3.2 Limited awareness among healthcare professionals and patients about the benefits of buccal drug delivery systems. |
4.3.3 High development costs associated with creating and commercializing innovative buccal drug delivery technologies. |
5 Belgium Buccal Drug Delivery Systems Market Trends |
6 Belgium Buccal Drug Delivery Systems Market, By Types |
6.1 Belgium Buccal Drug Delivery Systems Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Sublingual Films, 2021- 2031F |
6.1.4 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Buccal Tablets and Lozenges, 2021- 2031F |
6.1.5 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Oral Sprays, 2021- 2031F |
6.2 Belgium Buccal Drug Delivery Systems Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.3 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Smoking Cessation, 2021- 2031F |
6.2.4 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Angina Pectoris, 2021- 2031F |
6.3 Belgium Buccal Drug Delivery Systems Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Belgium Buccal Drug Delivery Systems Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
7 Belgium Buccal Drug Delivery Systems Market Import-Export Trade Statistics |
7.1 Belgium Buccal Drug Delivery Systems Market Export to Major Countries |
7.2 Belgium Buccal Drug Delivery Systems Market Imports from Major Countries |
8 Belgium Buccal Drug Delivery Systems Market Key Performance Indicators |
8.1 Patient acceptance rate of buccal drug delivery systems in Belgium. |
8.2 Number of clinical trials and research studies conducted on buccal drug delivery systems. |
8.3 Adoption rate of buccal drug delivery systems by healthcare facilities in Belgium. |
9 Belgium Buccal Drug Delivery Systems Market - Opportunity Assessment |
9.1 Belgium Buccal Drug Delivery Systems Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Belgium Buccal Drug Delivery Systems Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium Buccal Drug Delivery Systems Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Belgium Buccal Drug Delivery Systems Market - Competitive Landscape |
10.1 Belgium Buccal Drug Delivery Systems Market Revenue Share, By Companies, 2024 |
10.2 Belgium Buccal Drug Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |